Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004450415 | SCV004945907 | uncertain significance | not specified | 2021-08-23 | criteria provided, single submitter | clinical testing | The c.319G>A (p.G107S) alteration is located in exon 1 (coding exon 1) of the SELO gene. This alteration results from a G to A substitution at nucleotide position 319, causing the glycine (G) at amino acid position 107 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |